EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Multi-Omics Pan-Cancer Analysis of Procollagen N-Propeptidase Gene Family of ADAMTS as Novel Biomarkers to Associate with Prognosis, Tumor Immune Microenvironment, Signaling Pathways, and Drug Sensitivities

Yuxing Chen, Chaoyu Xiao, Qingxin Fan, Ye Zhang, Qiu Huang, Yunsheng Ou

Frontiers in Bioscience-Landmark · 2024

DOI: 10.31083/j.fbl2904151 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Bioscience-Landmark, 2024. Verfasst von Yuxing Chen und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopedics, The First Affiliated Hospital of Chongqing Medical University, 400016 Chongqing, China. Hauptthemen laut MEDLINE: Tumor Microenvironment, Signal Transduction, Neoplasms, Biomarkers, Tumor. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 69 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Chongqing Science and Technology Commission, Chongqing Graduate Research Innovation Project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The extracellular matrix (ECM) modeling induced by the metalloproteinases is a vital characteristic for tumor progression. Previous studies mainly focus on the functions of two subgroups of metalloproteinases: matrix metalloproteinases (MMPs) and a disintegrin and metalloproteases (ADAMs) in tumors. The roles of another important group: the ADAMs with thrombospondin motifs (ADAMTS) remain unclear. This study aimed to perform a pan-cancer analysis of procollagen N-propeptidase subgroup of ADAMTS (PNPSA).

Methods

We systematically analyzed expression landscape, genomic variations, prognostic value, and cell expression clusters of PNPSA in pan-cancer based on the multiple integrated open databases. Besides, we also analyzed the impacts of expressions and genomic variations of PNPSA members on tumor immune microenvironment (TIME) and immune-related molecules in pan-cancer based on the immune-related open databases. The Gene Set Variation Analysis (GSVA) was performed to evaluate the associations of the whole PNPSA with prognosis, tumor indicators, TIME, and drug sensitivities. Meanwhile, the Kyoto Encyclopedia of Genes and Genomes (KEGG) was performed to reveal related signaling pathways. Finally, immunohistochemical staining was used to validate the differential analysis results.

Results

We found a dual prognostic role of PNPSA members in pan-cancer and they were significantly correlated with TIME and immune-related molecules. Interestingly, the copy number variations (CNVs) of all PNPSA members were revealed to be negatively correlated with NK cell infiltration in most cancers. Single-cell sequencing analysis reveals expressions of PNPSA gene family members on some specific tumor and immune cells in addition to the fibroblasts. The GSVA score was found to have some predictive value for survival status in Brain Lower Grade Glioma (LGG), Mesothelioma (MESO), and Uveal Melanoma (UVM) and to be significantly correlated with tumorigenesis-related pathways such as PI3K-Akt, AGE-RAGE, etc. The GSVA score also shows some predictive value for chemotherapy and immunotherapy efficacy in some tumors.

Conclusions

PNPSA was correlated with tumor development and might be potential tumor biomarker and therapeutic target.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Tumor MicroenvironmentSignal TransductionNeoplasmsBiomarkers, TumorADAMTS ProteinsHumansPrognosisGene Expression Regulation, NeoplasticMultiomics

Stichwörter der Autor:innen

ADAMTSdrug sensitivitiesextracellular matrix (ECM)prognosissignaling pathwaystumor immune microenvironment (TIME)

Substanzen

Biomarkers, TumorADAMTS Proteins

Autor:innen und Institutionen

  • Department of Orthopedics, The First Affiliated Hospital of Chongqing Medical University, 400016 Chongqing, China.
  • Orthopedic Laboratory of Chongqing Medical University, 400016 Chongqing, China.

Förderung

  • National Natural Science Foundation of China
  • Chongqing Science and Technology Commission
  • Chongqing Graduate Research Innovation Project
  • First-class Discipline Construction Project of the First Affiliated Hospital of Chongqing Medical University

Zitieren

APA

Chen, Y., Xiao, C., Fan, Q., Zhang, Y., Huang, Q., & Ou, Y. (2024). Multi-Omics Pan-Cancer Analysis of Procollagen N-Propeptidase Gene Family of ADAMTS as Novel Biomarkers to Associate with Prognosis, Tumor Immune Microenvironment, Signaling Pathways, and Drug Sensitivities. Frontiers in Bioscience-Landmark. https://doi.org/10.31083/j.fbl2904151

Vancouver

Chen Y, Xiao C, Fan Q, Zhang Y, Huang Q, Ou Y. Multi-Omics Pan-Cancer Analysis of Procollagen N-Propeptidase Gene Family of ADAMTS as Novel Biomarkers to Associate with Prognosis, Tumor Immune Microenvironment, Signaling Pathways, and Drug Sensitivities. Frontiers in Bioscience-Landmark. 2024. doi:10.31083/j.fbl2904151

BibTeX
@article{Chen2024,
  author = {Chen, Yuxing and Xiao, Chaoyu and Fan, Qingxin and Zhang, Ye and Huang, Qiu and Ou, Yunsheng},
  title = {Multi-Omics Pan-Cancer Analysis of Procollagen N-Propeptidase Gene Family of ADAMTS as Novel Biomarkers to Associate with Prognosis, Tumor Immune Microenvironment, Signaling Pathways, and Drug Sensitivities},
  journal = {Frontiers in Bioscience-Landmark},
  year = {2024},
  doi = {10.31083/j.fbl2904151}
}
Kostenlos starten →